Latent tuberculosis infection tied to increased diabetes risk: Study
USA: A recent study in the journal Diabetes Care has suggested that people with latent tuberculosis infection (LTBI) are at an increased risk of developing diabetes. Cross-sectional U.S. studies have shown that diabetes patients are at twice the risk of latent tuberculosis infection versus those without diabetes. However, it is not known if LTBI is a contributor to diabetes risk. To fill...
USA: A recent study in the journal Diabetes Care has suggested that people with latent tuberculosis infection (LTBI) are at an increased risk of developing diabetes.
Cross-sectional U.S. studies have shown that diabetes patients are at twice the risk of latent tuberculosis infection versus those without diabetes. However, it is not known if LTBI is a contributor to diabetes risk. To fill this knowledge gap, Matthew J. Magee, School of Public Health, Georgia State University, Atlanta, GA, and colleagues aimed to determine if LTBI is associated with increased diabetes incidence using longitudinal data.
The researchers conducted a retrospective cohort study among U.S. Veterans receiving care in the Veterans Health Administration from 2000 to 2015. All patients without preexisting diabetes who received a tuberculin skin test (TST) or interferon-γ release assay (IGRA) were eligible for the study. Those with a history of active TB and those diagnosed with diabetes before or within 2 years after LTBI testing were excluded. Patients were followed until diabetes diagnosis, death, or 2015.
LTBI was defined as positive TST or IGRA. Incident diabetes was defined by the use of ICD-9 codes in combination with a diabetes drug prescription.
Based on the study, the researchers found the following:
- Among 574,113 eligible patients, 5.3% received both TST/IGRA, 79.1% received TST only, and 15.6% received IGRA only.
- Overall, 6.6% had LTBI, and there were 2,535,149 person-years (PY) of follow-up after LTBI testing (median 3.2 years).
- The diabetes incidence rate (per 100,000 PY) was greater in patients with LTBI compared with those without (1,012 vs. 744; hazard ratio [HR] 1.4).
- Increased diabetes incidence persisted after adjustment for covariates (adjusted HR [aHR] 1.2) compared with those without LTBI.
- Among patients with LTBI, diabetes incidence was similar in those treated for LTBI compared with those who were not treated (aHR 1.0).
The authors conclude, "comprehensive longitudinal data indicate that LTBI is associated with increased incidence of diabetes. These results have implications for people with LTBI, ∼25% of the global population."
Reference:
Matthew J. Magee, Anjali Khakharia, Neel R. Gandhi, Cheryl L. Day, Hardy Kornfeld, Mary K. Rhee, Lawrence S. Phillips; Increased Risk of Incident Diabetes Among Individuals With Latent Tuberculosis Infection. Diabetes Care 2022; dc211687. https://doi.org/10.2337/dc21-1687
Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement/treatment or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2024 Minerva Medical Treatment Pvt Ltd